Home › Metastatic Cancer › North Carolina › Cary
Metastatic Cancer clinical trials in Cary, NC
4 studies for Metastatic Cancer are looking for participants at sites in and around Cary (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Duke Cancer Center Cary, Cary
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- WakeMed Cancer Care - Waverly Hematology & Medical Oncology, Cary
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecruitingPhase 3
- WakeMed Health & Hospitals, Cary
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
RecruitingObservational study
- Duke Cancer Institute Cary, Cary
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Cary
- Obesity8 studies
- Overweight4 studies
- Macular Degeneration4 studies
- Colon Cancer4 studies
- Heart Failure3 studies
- Major Depressive Disorder3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.